US 7572887
Gene expressed in prostate cancer, methods and use thereof
granted A61KA61K38/164A61K38/168
Quick answer
US patent 7572887 (Gene expressed in prostate cancer, methods and use thereof) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K38/164, A61K38/168, A61K47/64